• Signal Amplification and the Hippo Pathway: Tools for Transl

  2026-07-07

  This in-depth thought-leadership article explores the mechanistic interplay between RNF166-driven Hippo pathway regulation in colorectal cancer and the strategic deployment of affinity-purified HRP Goat Anti-Rabbit IgG (H+L) Antibody for robust signal amplification in translational oncology research. Integrating mechanistic insights, experimental design guidance, and workflow optimization, it offers a roadmap for researchers seeking both biological clarity and technical excellence.

• Broad-Spectrum Bivalent mRNA Vaccine Counters SARS-CoV-2 Var

  2026-07-07

  A recent preclinical study introduces RQ3025, a bivalent mRNA vaccine designed to induce broad neutralizing immunity against multiple SARS-CoV-2 variants. The research demonstrates enhanced antibody responses and safety, advancing translational vaccine development for rapidly evolving viral threats.

• Jiedu Xiaozheng Yin Modulates Macrophage Polarization in CAC

  2026-07-06

  Liu et al. demonstrate that Jiedu Xiaozheng Yin (JXY) inhibits the progression of colitis-associated colorectal cancer by promoting M1 macrophage polarization through TLR4 signaling. This mechanistic insight highlights new avenues for immune modulation in tumor microenvironments and provides a foundation for integrating small molecule pathway inhibitors in translational research.

• Quinolone-Coumarin Hybrids as Novel Anti-Toxoplasma Agents

  2026-07-06

  This study introduces and evaluates quinolone–coumarin hybrids derived from fluoroquinolones and novobiocin for their selective in vitro anti-parasitic activity against Toxoplasma gondii. The findings identify several hybrids with promising efficacy and low host cell toxicity, offering new leads for the development of safer anti-toxoplasmosis therapies.

• NADH in Applied Mitochondrial Research: Protocols & Solution

  2026-07-05

  NADH (reduced nicotinamide adenine dinucleotide) is a pivotal coenzyme for mitochondrial research, enabling precise metabolic modeling and advanced disease assays. This article delivers actionable protocols, troubleshooting strategies, and insight into leveraging NADH for translational breakthroughs—including practical learnings from recent Sirtuin-focused studies.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Optimizing Endothe

  2026-07-04

  5-(N,N-dimethyl)-Amiloride hydrochloride enables precise dissection of Na+/H+ exchanger isoform roles in endothelial injury, pH regulation, and cardiac research. This article delivers practical workflows, troubleshooting strategies, and key insights for leveraging APExBIO’s high-purity inhibitor in advanced experimental models.

• PLK1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-07-03

  This study reveals how PLK1 directly regulates the activity of p31comet in the disassembly of the mitotic checkpoint complex (MCC) through site-specific phosphorylation. By uncovering a mechanism that prevents futile cycles of MCC assembly and disassembly, the findings clarify a fundamental aspect of mitotic checkpoint control with implications for cell cycle and cancer research.

• Moxidectin Boosts Polyene Antifungals via Ergosterol Upregul

  2026-07-03

  This study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, synergistically enhances polyene antifungal activity against Candida albicans by elevating ergosterol biosynthesis. These findings introduce a novel approach to improving oral candidiasis treatment and offer translational opportunities for drug repurposing.

• AP1903: Advancing Precision in Conditional Cell Ablation

  2026-07-02

  Explore how AP1903, a synthetic FKBP-binding ligand, redefines controlled protein activation and cell ablation in translational research. This article blends mechanistic insight, experimental rigor, strategic guidance, and vision, referencing recent breakthroughs in high-throughput virus-host compatibility assays and escalating the discussion beyond standard product summaries.

• Geneticin (G-418 Sulfate): Precision Selection and Translati

  2026-07-02

  This thought-leadership article explores the mechanistic underpinnings and best practices for deploying Geneticin (G-418 Sulfate) in translational research. Grounded in both molecular detail and strategic foresight, the discussion bridges genetic engineering, antiviral applications, and emerging cancer model insights—contextualizing the latest findings on immune evasion and therapy resistance in RCC. Evidence-based protocol guidance and a forward-looking outlook provide actionable intelligence for translational researchers.

• Intravesical p21 mRNA-LNP: Advancing Tumor Suppressor Therap

  2026-07-01

  This study pioneers the intravesical use of p21 mRNA-loaded lipid nanoparticles (LNPs) as a tumor suppressor replacement therapy for bladder cancer. By restoring p21 expression locally, the approach demonstrates robust tumor suppression while minimizing systemic exposure, offering a promising alternative to current localized treatments.

• (-)-JQ1: Assay-Specificity and Negative Controls in BRD4 Res

  2026-07-01

  Explore how (-)-JQ1, a key JQ1 stereoisomer, refines assay specificity as a negative control in epigenetics and cancer biology research. This article uniquely dissects the critical role of (-)-JQ1 in distinguishing BRD4-dependent mechanisms and highlights insights from emerging leukemia research.

• Lenalidomide (CC-5013) in Multiple Myeloma: Mechanistic Prec

  2026-06-30

  Explore how Lenalidomide (CC-5013) drives advanced multiple myeloma research through precise immune modulation and epigenetic interplay. This article reveals new mechanistic insights and practical assay guidance for leveraging this immune system activation agent.

• Smoothened’s Role in Honeybee Olfaction: Insights from Smo M

  2026-06-30

  Guo et al. (2024) deliver the first comprehensive molecular and functional characterization of the Smoothened (Smo) protein in Apis mellifera, establishing its pivotal influence on olfactory receptor expression and sensory-driven behavior. Their findings highlight new opportunities to dissect Hedgehog pathway function in insect sensory systems using pharmacological Smo modulators.

• Mutational Landscape in Myeloma Cell Lines: Drivers and Drug

  2026-06-29

  This study delivers the first comprehensive exome-wide characterization of mutations in 30 human multiple myeloma cell lines, revealing both established and novel genetic drivers linked to disease progression and drug resistance. The findings provide a valuable genomic resource for optimizing model selection and experimental design in hematological malignancy research, with direct implications for understanding therapeutic response.

16463 records 1/1098 page Next 12345 下5页 Last page